<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: One or more of the inherited <z:hpo ids='HP_0100724'>thrombophilias</z:hpo> may be causal risk factor for a proportion of <z:hpo ids='HP_0002140'>ischemic strokes</z:hpo>, but few studies have addressed this association or the association between <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> and pathogenic subtypes of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We conducted a case-control study of 219 hospital cases with a first-ever <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and 205 randomly selected community control subjects stratified by age, sex, and postal code </plain></SENT>
<SENT sid="2" pm="."><plain>With the use of established criteria, cases of <z:hpo ids='HP_0001297'>stroke</z:hpo> were classified by pathogenic subtype in a blinded fashion </plain></SENT>
<SENT sid="3" pm="."><plain>The prevalence of conventional vascular risk factors; fasting plasma levels of protein C, protein S, antithrombin III; and genetic tests for the factor V Leiden and the prothrombin 20210A mutation were determined in cases and control subjects </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The prevalence of any <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> was 14.7% (95% CI, 9.9% to 19.5%) among cases and 11.7% (95% CI, 7.4% to 17.0%) among control subjects (OR, 1.3; 95% CI, 0.7% to 2.3%) </plain></SENT>
<SENT sid="5" pm="."><plain>The prevalence of individual <z:hpo ids='HP_0100724'>thrombophilias</z:hpo> among cases ranged from 0.9% (95% CI, 0.1% to 3.4%) for <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e> to 5.2% (95% CI, 0.3% to 9.1%) for <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo>; among control subjects, the prevalence ranged from 1.0% (95% CI, 0.1% to 3.6%) for <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e> to 4.1% (95% CI, 0.2% to 7.8%) for <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>There were no significant differences in the prevalence of <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> between cases and control subjects or between pathogenic subtypes of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: One in 7 patients with first-ever <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> will test positive for one of the inherited <z:hpo ids='HP_0100724'>thrombophilias</z:hpo>, but the relation is likely to be coincidental rather than causal in almost <z:hpo ids='HP_0000001'>all</z:hpo> cases, irrespective of the pathogenic subtype of the <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>These results suggest that routine testing for <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> in most patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> may be unnecessary </plain></SENT>
<SENT sid="9" pm="."><plain>Whether the <z:hpo ids='HP_0100724'>thrombophilias</z:hpo> may still be important in younger patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> or in predicting complications (eg, <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>) and <z:hpo ids='HP_0001297'>stroke</z:hpo> outcome remains uncertain </plain></SENT>
</text></document>